title: [Prostate cancer, androgenic suppression and associated conditions. Practical refinement by a panel of multidisciplinary experts for patient integral management].
authors.forename: P
authors.initials: P
authors.lastname: Coloby
authors.forename: L
authors.initials: L
authors.lastname: Boccon-Gibod
authors.forename: C
authors.initials: C
authors.lastname: Coulange
authors.forename: S
authors.initials: S
authors.lastname: Culine
authors.forename: J-L
authors.initials: JL
authors.lastname: Davin
authors.forename: P
authors.initials: P
authors.lastname: Richaud
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: M
authors.initials: M
authors.lastname: Soulié
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists